# Parke Bancorp, Inc.: overview

PKBK · Nasdaq · CIK 1315399 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pkbk.md) · [Financials](/companies/pkbk/financials.md) · [Filings](/companies/pkbk/filings.md) · [Insiders](/companies/pkbk/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.62](/filings/0001437749-25-033355.md) | not reported | [0.65](/filings/0001437749-26-015152.md) | [0.69](/filings/0001437749-26-025857.md) | [0.89](/filings/0001437749-25-033355.md) | not reported | [0.99](/filings/0001437749-26-015152.md) | [1.03](/filings/0001437749-26-025857.md) |
| Free cash flow | $m | [9.4 d](/filings/0001437749-25-033355.md) | [8.5 d](/filings/0001437749-26-007748.md) | [6.6](/filings/0001437749-26-015152.md) | [6.7 d](/filings/0001437749-26-025857.md) | [11.2 d](/filings/0001437749-25-033355.md) | [14.4 d](/filings/0001437749-26-007748.md) | [13.0](/filings/0001437749-26-015152.md) | [5.9 d](/filings/0001437749-26-025857.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [3.36](/filings/0001315399-23-000020.md) | [3.44](/filings/0001315399-24-000024.md) | [2.35](/filings/0001315399-25-000025.md) | [2.27](/filings/0001437749-26-007748.md) | [3.16](/filings/0001437749-26-007748.md) |
| Free cash flow | $m | [38.6](/filings/0001315399-23-000020.md) | [43.3](/filings/0001315399-24-000024.md) | not reported | [35.0](/filings/0001437749-26-007748.md) | [39.0](/filings/0001437749-26-007748.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pkbk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $26.0m | 785,130 |  | Added +166,417 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $21.2m | 639,022 |  | Added +39,813 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $15.3m | 459,915 |  | Added +6,100 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $12.1m | 364,544 |  | Added +101,498 |
| [Ategra Capital Management, LLC](/funds/1741369.md) | 2026-06-30 | $11.4m | 343,842 |  | Reduced −30,305 |
| [Cutler Capital Management, LLC](/funds/1353098.md) | 2026-06-30 | $10.4m | 314,126 |  | Reduced −3,300 |
| [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $9.7m | 291,183 |  | Reduced −2,256 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $9.6m | 288,594 |  | Added +62,576 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $8.5m | 256,786 |  | Added +106,945 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $7.5m | 226,347 |  | Added +27,400 |

## Recent filings

[All 714 filings](/companies/pkbk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 08:32 ET | [8-K](/filings/0001437749-26-033062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033062 |
| 2026-09-24 | 15:02 ET | [8-K](/filings/0001437749-26-031135.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-031135 |
| 2026-09-22 | 17:02 ET | [8-K](/filings/0001437749-26-030935.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030935 |
| 2026-08-05 | 13:15 ET | [10-Q](/filings/0001437749-26-025857.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025857 |
| 2026-07-22 | 08:33 ET | [8-K](/filings/0001437749-26-024045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024045 |
| 2026-06-18 | 08:45 ET | [8-K](/filings/0001437749-26-021045.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021045 |
| 2026-05-22 | 08:31 ET | [8-K](/filings/0001437749-26-018179.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-018179 |
| 2026-05-06 | 14:29 ET | [10-Q](/filings/0001437749-26-015152.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015152 |
| 2026-04-24 | 08:10 ET | [8-K](/filings/0001437749-26-013237.md) | 5.07 Shareholder vote results | 0001437749-26-013237 |
| 2026-04-21 | 08:31 ET | [8-K](/filings/0001437749-26-012883.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012883 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-007748.md), filed Mar 11, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1315399
- Tickers: PKBK
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: NJ
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 14:32 ET. No prices; not investment advice.
